Lucon 50 mg (Capsule)

Unit Price: ৳ 8.06 (3 x 10: ৳ 241.74)

Strip Price: ৳ 80.58

Medicine Details

Vaginal Candidiasis
Oropharyngeal Candidiasis
Oesophageal Candidiasis
Tinea corporis/Tinea cruris/Tinea pedis/Other Tinea
Kerion
Pityriasis versicolor
Onychomycosis
Invasive candidal infections and cryptococcal infections (including meningitis)
Prevention of cryptococcal meningitis
Prevention of fungal infections in immunocompromised patients
Systemic Candidiasis and Cryptococcal infection
Superficial Candidiasis
Fungal urinary tract infections
Disseminated candidiasis
Prophylaxis for fungal infection in neutropenic cancer patients
Acute treatment of other systemic fungal infections such as coccidioidomycosis and histoplasmosis

Triazole antifungal agent

Adults:
- Vaginal Candidiasis: 150 mg as a single dose
- Oropharyngeal Candidiasis: 200 mg in 1st day followed by 100 mg daily for 14 days
- Oesophageal Candidiasis: 200 mg in 1st day followed by 100 mg daily for 14-30 days
- Tinea corporis/Tinea cruris/Tinea pedis/Other Tinea: 150 mg weekly for 4-6 weeks
- Kerion: 50 mg daily for 20 days
- Pityriasis versicolor: 400 mg as a single dose
- Onychomycosis: 150 mg weekly for 12 months
- Invasive candidal infections and cryptococcal infections: Orally or by IV infusion, 400 mg on first day then 200-400 mg daily
- Prevention of cryptococcal meningitis: Orally or by IV infusion 200 mg daily
- Prevention of fungal infections in immunocompromised patients: Orally or by IV infusion, 50-400 mg daily
Children:
- In Superficial Candidiasis: 1-2 mg/kg daily
- In Systemic Candidiasis & Cryptococcal infection: 3-6 mg/kg daily
Use in Specific Population:
- Elderly patient: Normal dose should be used if there is no evidence of renal impairment
- Renal Impairment: Dosage intervals should be modified based on creatinine clearance

Increased prothrombin time after warfarin administration
Prolonged serum half-life of concomitantly administed oral sulphonyl ureas
Increased plasma concentrations of fuconazole by 40% with co-administration of multiple-dose hydrochlorothiazide
Increased level of phenytoin
25% decrease in the AUC and 20% shorter half-life of fuconazole with rifampicin administration

Known hypersensitivity to Fluconazole or related triazole compounds

Not recommended unless adequate contraception is employed

Abnormalities of hepatic, renal, haematological and other biochemical function tests
Rare exfoliative cutaneous reactions
Hepatic necrosis risk
Cutaneous reactions monitoring during therapy
Not recommended during lactation

Elderly: Normal dose should be used if there is no evidence of renal impairment
Renal Impairment: Dosage intervals should be modified based on creatinine clearance

Supportive measures and symptomatic treatment, forced volume diuresis, haemodialysis